Finance

Lists
ALIVUS:NSE
Alivus Life Sciences Ltd
1 380,00 INR
-0,29%
(-4,00) 1D
7 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALIVUS...
Open
1 389,90 INR
High
1 389,90 INR
Low
1 361,60 INR
Mkt. cap
169,49 მლრ.
Avg. vol.
174,50 ათ.
Volume
79,36 ათ.
Dividend
0,36%
Quarterly dividend
1,25 INR
Ex-dividend date
1 სექ. 2026
P/E ratio
28,15
52-wk high
1 493,80 INR
52-wk low
819,00 INR
EPS
49,03 INR
No. of employees
2 ათ.
Open
1 389,90 INR
High
1 389,90 INR
Low
1 361,60 INR
Mkt. cap
169,49 მლრ.
Avg. vol.
174,50 ათ.
Volume
79,36 ათ.
Dividend
0,36%
Quarterly dividend
1,25 INR
Ex-dividend date
1 სექ. 2026
P/E ratio
28,15
52-wk high
1 493,80 INR
52-wk low
819,00 INR
EPS
49,03 INR
No. of employees
2 ათ.
News stories
From web sources and news partners
About Alivus Life Sciences Ltd
CEOიასირ რაუჯი
Employees2,27 ათ.
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com
Last report
31 ივლ. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
13,01 INR / 12,10 INR
+7,52%beat
Revenue / Est. (INR)
6,40 მლრდ. / 6,68 მლრდ.
-4,06%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,88 მლრდ.
6,73 მლრდ.
6,89 მლრდ.
6,40 მლრდ.
Cost of goods sold
2,49 მლრდ.
2,76 მლრდ.
3,45 მლრდ.
2,55 მლრდ.
Cost of revenue
2,49 მლრდ.
2,76 მლრდ.
3,45 მლრდ.
2,55 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
664,00 მლნ.
663,70 მლნ.
965,39 მლნ.
682,45 მლნ.
Operating expense
1,78 მლრდ.
1,85 მლრდ.
1,49 მლრდ.
1,94 მლრდ.
Total operating expenses
4,27 მლრდ.
4,61 მლრდ.
4,94 მლრდ.
4,49 მლრდ.
Operating income
1,61 მლრდ.
2,12 მლრდ.
1,95 მლრდ.
1,91 მლრდ.
Other non operating income
147,20 მლნ.
139,28 მლნ.
-368,69 მლნ.
224,01 მლნ.
EBT including unusual items
1,74 მლრდ.
1,98 მლრდ.
2,16 მლრდ.
2,12 მლრდ.
EBT excluding unusual items
1,74 მლრდ.
2,24 მლრდ.
1,78 მლრდ.
2,12 მლრდ.
Income tax expense
441,11 მლნ.
481,31 მლნ.
531,38 მლნ.
521,47 მლნ.
Effective tax rate
25,33%
24,26%
24,62%
24,57%
Other operating expenses
934,91 მლნ.
988,28 მლნ.
325,80 მლნ.
1,05 მლრდ.
Net income
1,30 მლრდ.
1,50 მლრდ.
1,63 მლრდ.
1,60 მლრდ.
Net profit margin
22,11%
22,33%
23,60%
25,00%
Earnings per share
10,58
13,80
13,22
13,01
Interest and investment income
-
-
9,66 მლნ.
-
Interest expense
-13,18 მლნ.
-14,94 მლნ.
-13,09 მლნ.
-13,07 მლნ.
Net interest expenses
-13,18 მლნ.
-14,94 მლნ.
-3,43 მლნ.
-13,07 მლნ.
Depreciation and amortization charges
184,35 მლნ.
196,58 მლნ.
202,00 მლნ.
205,85 მლნ.
EBITDA
1,78 მლრდ.
2,25 მლრდ.
2,11 მლრდ.
2,10 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები